Universitat Internacional de Catalunya (UIC-Barcelona), Barcelona, Spain.
Médico Quirónsalud Aribau, Barcelona, Spain.
Pain Med. 2021 Jul 25;22(7):1630-1641. doi: 10.1093/pm/pnab114.
Dry needling is commonly used for the management of plantar fasciitis. This meta-analysis evaluated the effects of dry needling over trigger points associated with plantar heel pain on pain intensity and related disability or function.
Electronic databases were searched for randomized controlled trials in which at least one group received dry needling, not acupuncture, for trigger points associated with plantar heel pain and in which outcomes were collected on pain intensity and related disability. The risk of bias was assessed with the Cochrane Risk of Bias tool, methodological quality was assessed with the Physiotherapy Evidence Database (PEDro) score, and the level of evidence is reported according to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. Between-groups mean differences (MD) and standardized mean differences (SMD) were calculated.
The search identified 297 publications, with six trials eligible for inclusion. The meta-analysis found low-quality evidence that trigger point dry needling reduces pain intensity in the short term (MD -1.70 points, 95% confidence interval [CI] -2.80 to -0.60; SMD -1.28, 95% CI -2.11 to -0.44) and moderate-quality evidence that it improves pain intensity (MD -1.77 points, 95% CI -2.44 to -1.11; SMD -1.45, 95% CI -2.19 to -0.70) and related disability (SMD -1.75, 95% CI -2.22 to -1.28) in the long term, as compared with a comparison group. The risk of bias of the trials was generally low, but the heterogeneity of the results downgraded the level of evidence.
Moderate- to low-quality evidence suggests a positive effect of trigger point dry needling for improving pain intensity and pain-related disability in the short term and long term, respectively, in patients with plantar heel pain of musculoskeletal origin. The present results should be considered with caution because of the small number of trials.
干针疗法常用于足底筋膜炎的治疗。本荟萃分析评估了针对足底跟痛相关触发点的干针疗法对疼痛强度以及相关残疾或功能的影响。
检索电子数据库,查找至少有一组接受针对足底跟痛相关触发点的干针治疗(而非针刺),且收集疼痛强度及相关残疾结局的随机对照试验。使用 Cochrane 偏倚风险工具评估偏倚风险,使用物理治疗证据数据库(PEDro)评分评估方法学质量,并根据推荐评估、制定与评价(GRADE)方法报告证据等级。计算组间均数差值(MD)和标准化均数差值(SMD)。
检索共确定了 297 篇文献,其中 6 项试验符合纳入标准。荟萃分析结果表明,触发点干针疗法在短期可降低疼痛强度(MD-1.70 点,95%置信区间 [CI]-2.80 至-0.60;SMD-1.28,95% CI-2.11 至-0.44),且具有低质量证据,长期可改善疼痛强度(MD-1.77 点,95% CI-2.44 至-1.11;SMD-1.45,95% CI-2.19 至-0.70)和相关残疾(SMD-1.75,95% CI-2.22 至-1.28),与对照组相比。试验的偏倚风险总体较低,但结果的异质性降低了证据等级。
中低质量证据表明,针对足底跟痛相关触发点的干针疗法在短期和长期分别可有效改善疼痛强度和与疼痛相关的残疾,这对肌肉骨骼源性足底跟痛患者具有重要意义。鉴于试验数量较少,本研究结果应谨慎解读。